Understanding how to create effective HIV vaccines targeting specific protein regions
Structural characterization of MPER-TM immunogens
This study is looking at parts of the HIV virus that can help create stronger vaccines, aiming to protect people from HIV by making it easier for the body to fight the virus.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11062384 on NIH RePORTER |
What this research studies
This research focuses on identifying and characterizing specific regions of the HIV-1 envelope protein that are crucial for eliciting broadly neutralizing antibodies (bnAbs). By utilizing advanced techniques like cryo-electron microscopy and molecular dynamics simulations, the project aims to develop mRNA-based chimeric vaccines that can effectively target these vulnerable sites. The goal is to enhance the immunogenicity of the membrane-proximal external region (MPER) of the HIV-1 protein, which is essential for preventing viral entry into host cells. Patients may benefit from this research through the development of more effective vaccines against HIV.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at high risk for HIV infection or those living with HIV who may benefit from improved vaccine strategies.
Not a fit: Patients who are not at risk for HIV or those who have already achieved viral suppression through existing treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of a more effective HIV vaccine that provides broader protection against various strains of the virus.
How similar studies have performed: Other research has shown promise in targeting similar regions of the HIV envelope protein, indicating that this approach could lead to significant advancements in vaccine development.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Reinherz, Ellis L — Dana-Farber Cancer Inst
- Study coordinator: Reinherz, Ellis L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.